# AstraZeneca and insitro Announce AI Drug Discovery Deal Valued at Up to $1.5 Billion By John Kim Canonical URL: https://www.tokenpost.com/news/business/32513 Published: 2026-10-15T12:50:23.000Z Updated: 2026-10-15T12:50:23.000Z Section: Business > The two companies plan to identify drug targets together and advance them. AstraZeneca and insitro announced an AI-assisted drug discovery and licensing deal worth up to $1.5 billion on Oct. 15, with plans to identify drug targets and advance them together. insitro is a California-based biotech, while AstraZeneca is an Anglo-Swedish drugmaker. A separate South San Francisco [AI lab project]() from Eli Lilly and NVIDIA involves planned investment of up to $1 billion over five years for drug discovery, manufacturing and related work. ## Links in this article - [AI lab project](https://www.tokenpost.com/news/business/28193)